FDA Announces “Proactive” Approach To Rx-To-OTC Switches
This article was originally published in The Tan Sheet
Executive Summary
FDA plans to take a more active role in initiating Rx-to OTC switches in coming years, Senior Associate Commissioner for Management & Systems Jeff Weber said Feb. 3